Adjuvant nivolumab for gastric and gastro-oesophageal junction cancer - Authors' reply.

Lancet Gastroenterol Hepatol

Department of Surgery, Yodogawa Christian Hospital, Osaka 533-0024, Japan. Electronic address:

Published: December 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(24)00302-9DOI Listing

Publication Analysis

Top Keywords

adjuvant nivolumab
4
nivolumab gastric
4
gastric gastro-oesophageal
4
gastro-oesophageal junction
4
junction cancer
4
cancer authors'
4
authors' reply
4
adjuvant
1
gastric
1
gastro-oesophageal
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!